Peer Review reports
From: Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
| Original Submission | ||
|---|---|---|
| 8 Aug 2014 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 28 Aug 2014 | Reviewed | Reviewer Report - Brian Hasinoff |
| 4 Sep 2014 | Reviewed | Reviewer Report - Philippe Pourquier |
| 8 Oct 2014 | Author responded | Author comments - Shiwei Deng |
| Resubmission - Version 3 | ||
| 8 Oct 2014 | Submitted | Manuscript version 3 |
| 22 Oct 2014 | Author responded | Author comments - Shiwei Deng |
| Resubmission - Version 4 | ||
| 22 Oct 2014 | Submitted | Manuscript version 4 |
| 29 Oct 2014 | Author responded | Author comments - Shiwei Deng |
| Resubmission - Version 5 | ||
| 29 Oct 2014 | Submitted | Manuscript version 5 |
| Publishing | ||
| 4 Nov 2014 | Editorially accepted | |
| 18 Nov 2014 | Article published | 10.1186/1471-2407-14-842 |
You can find further information about peer review here.